A H Brouwers Selected Research

Programmed Cell Death 1 Receptor

1/2022

89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A H Brouwers Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 09/2009
6	Melanoma (Melanoma, Malignant) 01/2022 - 03/2011
5	Breast Neoplasms (Breast Cancer) 12/2018 - 10/2009
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 04/2023 - 01/2017
2	Primary Hyperparathyroidism 04/2023 - 01/2017
2	Adenoma (Adenomas) 03/2021 - 09/2009
2	Neoplasm Metastasis (Metastasis) 09/2020 - 02/2008
2	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 01/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2008 - 03/2002
2	Escherichia coli Infections 11/2000 - 06/2000
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Thyroid Diseases (Thyroid Disease) 01/2021
1	Disease Progression 11/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Lymphatic Metastasis 02/2012
1	Necrosis 02/2012
1	Vulvar Neoplasms (Vulvar Cancer) 02/2011
1	Thyroid Neoplasms (Thyroid Cancer) 01/2011
1	Secondary Hyperparathyroidism 09/2009
1	Inflammation (Inflammations) 11/2000
1	Abscess 11/2000
1	Infections 11/2000

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 11/2020 - 02/2012
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 04/2016
4	zirconium-89-trastuzumabIBA 12/2018 - 10/2009
2	Cetuximab (Erbitux)FDA Link 09/2020 - 01/2020
2	Coloring Agents (Dyes)IBA 04/2016 - 02/2011
2	Radioisotopes (Radionuclides)IBA 10/2009 - 03/2002
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 04/2023
1	fluorocholineIBA 04/2023
1	pembrolizumabIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 09/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2020
1	human ERBB2 proteinIBA 12/2018
1	Parathyroid Hormone (Parathormone)IBA 01/2017
1	CalciumIBA 01/2017
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 04/2016
1	Ado-Trastuzumab EmtansineIBA 04/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Bevacizumab (Avastin)FDA Link 02/2012
1	Radioactive TracersIBA 02/2011
1	Thyroglobulin FDA Link 01/2011
1	Trastuzumab (Herceptin)FDA Link 05/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2009
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2009
1	Estrogen ReceptorsIBA 10/2009
1	Growth Factor ReceptorsIBA 10/2009
1	multidrug resistance-associated protein 1IBA 09/2009
1	Multidrug Resistance-Associated ProteinsIBA 09/2009
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2009
1	Cytotoxins (Cytolysins)IBA 02/2008
1	Interferon-alpha (Interferon Alfa)IBA 02/2008
1	Monoclonal AntibodiesIBA 03/2002
1	Deoxyglucose (2 Deoxy D glucose)IBA 03/2002
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 11/2000
1	RP517IBA 11/2000
1	hydrazino nicotinamideIBA 11/2000
1	Liposomes (Liposome)IBA 06/2000

Therapy/Procedure

6	Therapeutics 09/2020 - 10/2009
4	Parathyroidectomy 04/2023 - 09/2009
2	Lymph Node Excision (Lymph Node Dissection) 02/2012 - 03/2011
1	Neck Dissection (Radical Neck Dissection) 08/2018
1	Injections 02/2011
1	Radiotherapy 02/2008
1	Immunotherapy 02/2008
1	Metastasectomy 02/2008